Capital BioVentures (CBV), a leading biotech accelerator, dedicated to supporting the growth of early-stage life sciences companies, is proud to announce the launch of its newest offering, the ASCENT Program. Designed to accelerate the development and funding readiness of promising therapeutic startups, ASCENT is a virtual six-month program providing expert-led seminars, workshops, office hours, one-on-one coaching from seasoned executives, strategic investor exposure, and 360 feedback. This program is supported by the Government of Canada through funding from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).